John Armitage’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,182,907
Closed -$349M 25
2026
Q1
$349M Buy
1,182,907
+3,115
+0.3% +$925K 3.88% 11
2025
Q4
$322M Sell
1,179,792
-4,996
-0.4% -$1.36M 3.5% 11
2025
Q3
$320M Sell
1,184,788
-338,148
-22% -$92M 3.38% 15
2025
Q2
$420M Sell
1,522,936
-207,258
-12% -$56.4M 4.31% 9
2025
Q1
$459M Buy
1,730,194
+765,773
+79% +$189M 5.3% 6
2024
Q4
$224M Buy
+964,421
New +$222M 2.59% 17
2021
Q2
Sell
-449,800
Closed -$91.9M 33
2021
Q1
$91.9M Sell
449,800
-449
-0.1% -$88.4K 0.48% 34
2020
Q4
$82M Buy
+450,249
New +$76.6M 0.46% 33

Other funds holding CME

John Armitage's CME Position: Q2 2026 in Review

John Armitage sold out of CME Group (CME) in Q2 2026, closing a stake of 1,182,907 shares — an estimated $349M sold.

John Armitage first reported a position in CME in Q4 2020 and held it in 8 quarters. The position peaked at $459M in Q1 2025. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • John Armitage reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • John Armitage sold 1,182,907 CME Group shares in Q2 2026, an estimated $349M.
  • John Armitage first reported a position in CME Group in Q4 2020 and held it in 8 quarters.
  • John Armitage's CME Group position peaked at $459M in Q1 2025.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Egerton Capital (UK)'s 13F filing for Q2 2026, filed 21 Jul 2026.